ARID1A deficiency promotes progression and potentiates therapeutic antitumour immunity in hepatitis B virus-related hepatocellular carcinoma.
Journal Information
Full Title: BMC Gastroenterol
Abbreviation: BMC Gastroenterol
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Subject Category: Gastroenterology & Hepatology
Available in Europe PMC: Yes
Available in PMC: Yes
PDF Available: No
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"Declarations Ethics approval and consent to participateThe study was conducted following Helsinki Declaration. The Ethical clearance was approved by The Institutional Review Board of Peking University International Hospital. All patients or their legal guardians provided written informed consent for this study. Consent for publicationNot applicable. Competing interestsThe authors declare no competing interests. Competing interests The authors declare no competing interests."
"Funding This study was supported by grants from the National Natural Science Foundation of China (no. 82202882) and the Beijing Xisike Clinical Oncology Research Foundation (no. Y-BMS2019-015, Y-HS2019-33 and Y-MX2015-073) and the Beijing CSCO Oncology Research Foundation (no. Y-HS2019/2-056)."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025